81 related articles for article (PubMed ID: 4064047)
1. Urinary excretion of modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS.
Fischbein A; Sharma OK; Valciukas JA; Bekesi JG; Buschman F; Apell G; Kohn M; Boesch RR; Teirstein A; Selikoff IJ
Cancer Detect Prev; 1985; 8(1-2):271-7. PubMed ID: 4064047
[TBL] [Abstract][Full Text] [Related]
2. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters.
Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK
Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786
[TBL] [Abstract][Full Text] [Related]
3. Altered excretion of modified nucleosides and beta-aminoisobutyric acid in subjects with acquired immunodeficiency syndrome or at risk for acquired immunodeficiency syndrome.
Borek E; Sharma OK; Buschman FL; Cohn DL; Penley KA; Judson FN; Dobozin BS; Horsburgh CR; Kirkpatrick CH
Cancer Res; 1986 May; 46(5):2557-61. PubMed ID: 3008993
[TBL] [Abstract][Full Text] [Related]
4. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
[TBL] [Abstract][Full Text] [Related]
5. Estimation of whole-body RNA catabolism based on the urinary modified nucleoside levels of cancer and AIDS patients.
Nakano K; Nakao T; Schram KH; Hammargren WM
Nucleic Acids Symp Ser; 1991; (25):125-6. PubMed ID: 1726802
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
Fischbein A; Sharma OK; Selikoff IJ; Borek E
Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
[TBL] [Abstract][Full Text] [Related]
7. Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis.
Smith PD; Ohura K; Masur H; Lane HC; Fauci AS; Wahl SM
J Clin Invest; 1984 Dec; 74(6):2121-8. PubMed ID: 6511917
[TBL] [Abstract][Full Text] [Related]
8. Transfer RNA breakdown products in the urine of asbestos workers.
Fischbein A; Sharma OK; Solomon S; Buschman F; Apell G; Kohn M; Selikoff IJ; Bekesi JG; Borek E
Cancer Detect Prev; 1984; 7(4):247-52. PubMed ID: 6488216
[TBL] [Abstract][Full Text] [Related]
9. Transfusion associated AIDS in Mexico. Clinical spectrum, conditional latency distribution, and survival.
Volkow P; Ponce de León S; Calva J; Ruiz-Palacios G; Mohar A
Rev Invest Clin; 1993; 45(2):133-8. PubMed ID: 8337540
[TBL] [Abstract][Full Text] [Related]
10. [AIDS and the eye].
Grasl M; Radda T; Hutterer J
Klin Monbl Augenheilkd; 1985 Nov; 187(5):457-9. PubMed ID: 4087813
[TBL] [Abstract][Full Text] [Related]
11. HIV infection and AIDS.
Lloyd A
P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group.
Hermans P; Lundgren J; Sommereijns B; Pedersen C; Vella S; Katlama C; Lüthy R; Pinching AJ; Gerstoft J; Pehrson P; Clumeck N
AIDS; 1996 Jul; 10(8):911-7. PubMed ID: 8828749
[TBL] [Abstract][Full Text] [Related]
13. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma and AIDS in Uganda: its frequency and gastrointestinal distribution.
Ravera M; Reggiori A; Cocozza E; Andreata M; Ciantia F
Ital J Gastroenterol; 1994 Sep; 26(7):329-33. PubMed ID: 7812024
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma and community-acquired immune deficiency syndrome.
Abemayor E; Calcaterra TC
Arch Otolaryngol; 1983 Aug; 109(8):536-42. PubMed ID: 6307239
[TBL] [Abstract][Full Text] [Related]
16. Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.
Biggar RJ; Horm J; Fraumeni JF; Greene MH; Goedert JJ
J Natl Cancer Inst; 1984 Jul; 73(1):89-94. PubMed ID: 6588239
[TBL] [Abstract][Full Text] [Related]
17. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of acquired immunodeficiency syndrome malignancies.
Goedert JJ
Semin Oncol; 2000 Aug; 27(4):390-401. PubMed ID: 10950365
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
20. Cancer incidence in AIDS patients in Catalonia, Spain.
Galceran J; Marcos-Gragera R; Soler M; Romaguera A; Ameijide A; Izquierdo A; Borràs J; de Sanjosé S; Casabona J
Eur J Cancer; 2007 Apr; 43(6):1085-91. PubMed ID: 17349785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
